H.R. 10628: To amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.

Loading bill details...

Initial load may take a moment while we fetch the latest data

H.R. 10628: To amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program. | CIV.IQ